HIV Posterior Cheek Enlargement

Posterior Cheek Enlargement in HIV: Anatomic Characterization and Treatment With Botulinum Toxin A

NCT01635504•University of British Columbia

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

HIV Posterior Cheek Enlargement

Interventions

Botulinum toxin A

Locations

Canada

Locations (1)

Carruthers Dermatology Center

Vancouver, British Columbia, Canada

Key Dates

Start Date

October 1, 2012

Primary Completion Date

January 1, 2015

Completion Date

January 1, 2015

Last Updated

August 28, 2015

Sponsors

Lead Sponsor

University of British Columbia

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 28, 2015Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions